Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1

Status

Completed 4Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 4354Neoplasms 3055Prostatic Neoplasms 1904Colorectal Neoplasms 1738Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Multiple Myeloma 951Leukemia, Myeloid, Acute 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 740Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

Tumor Necrosis Factor Inhibitors 1Radioimmunodetection 1Etanercept 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Spondylarthritis × Clear all
NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase 4 Completed
31 enrolled

Spondylarthritis

NCT02492217 2020-11-03

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Universidade Nova de Lisboa

Phase 4 Completed
69 enrolled

Spondylitis, Ankylosing, Spondylarthritis

NCT02364479 2019-12-19

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Sun Yat-sen University

Phase 4 Completed
150 enrolled

Recurrence, Spondylarthritis

NCT01590966 2019-08-26

SCINTRA

University Hospital, Ghent

Phase 3 Completed
41 enrolled

Arthritis, Rheumatoid, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡